These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 19422381)

  • 1. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.
    Schäcke H; Zollner TM; Döcke WD; Rehwinkel H; Jaroch S; Skuballa W; Neuhaus R; May E; Zügel U; Asadullah K
    Br J Pharmacol; 2009 Oct; 158(4):1088-103. PubMed ID: 19422381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects.
    Schäcke H; Schottelius A; Döcke WD; Strehlke P; Jaroch S; Schmees N; Rehwinkel H; Hennekes H; Asadullah K
    Proc Natl Acad Sci U S A; 2004 Jan; 101(1):227-32. PubMed ID: 14694204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist.
    Baiula M; Spartà A; Bedini A; Carbonari G; Bucolo C; Ward KW; Zhang JZ; Govoni P; Spampinato S
    Mol Vis; 2011; 17():3208-23. PubMed ID: 22194647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The selective glucocorticoid receptor agonist mapracorat displays a favourable safety-efficacy ratio for the topical treatment of inflammatory skin diseases in dogs.
    Bäumer W; Rossbach K; Schmidt BH
    Vet Dermatol; 2017 Feb; 28(1):46-e11. PubMed ID: 27425245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy.
    Baiula M; Bedini A; Baldi J; Cavet ME; Govoni P; Spampinato S
    Drug Des Devel Ther; 2014; 8():745-57. PubMed ID: 24959069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mapracorat, a novel non-steroidal selective glucocorticoid receptor agonist for the treatment of allergic conjunctivitis.
    Baiula M; Spampinato S
    Inflamm Allergy Drug Targets; 2014; 13(5):289-98. PubMed ID: 25373600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells.
    Zhang JZ; Cavet ME; VanderMeid KR; Salvador-Silva M; López FJ; Ward KW
    Mol Vis; 2009 Dec; 15():2606-16. PubMed ID: 20011631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo ocular efficacy profile of mapracorat, a novel selective glucocorticoid receptor agonist, in rabbit models of ocular disease.
    Shafiee A; Bucolo C; Budzynski E; Ward KW; López FJ
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1422-30. PubMed ID: 20881303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-inflammatory effects of selective glucocorticoid receptor modulators are partially dependent on up-regulation of dual specificity phosphatase 1.
    Joanny E; Ding Q; Gong L; Kong P; Saklatvala J; Clark AR
    Br J Pharmacol; 2012 Feb; 165(4b):1124-36. PubMed ID: 21718312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial pharmacological effects of selective glucocorticoid receptor agonist in external eye diseases.
    Kato M; Hagiwara Y; Oda T; Imamura-Takai M; Aono H; Nakamura M
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):353-60. PubMed ID: 21574866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapracorat, a selective glucocorticoid receptor agonist, upregulates RelB, an anti-inflammatory nuclear factor-kappaB protein, in human ocular cells.
    Spinelli SL; Xi X; McMillan DH; Woeller CF; Richardson ME; Cavet ME; Zhang JZ; Feldon SE; Phipps RP
    Exp Eye Res; 2014 Oct; 127():290-8. PubMed ID: 25245083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells.
    Cavet ME; Volhejn S; Harrington KL; Zhang JZ
    Mol Vis; 2013; 19():1515-25. PubMed ID: 23878502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior nuclear receptor selectivity and therapeutic index of methylprednisolone aceponate versus mometasone furoate.
    Mirshahpanah P; Döcke WD; Merbold U; Asadullah K; Röse L; Schäcke H; Zollner TM
    Exp Dermatol; 2007 Sep; 16(9):753-61. PubMed ID: 17697148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of quinolines as selective glucocorticoid receptor agonists.
    Jaroch S; Berger M; Huwe C; Krolikiewicz K; Rehwinkel H; Schäcke H; Schmees N; Skuballa W
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5835-8. PubMed ID: 20727743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced myocilin expression in cultured monkey trabecular meshwork cells induced by a selective glucocorticoid receptor agonist: comparison with steroids.
    Pfeffer BA; DeWitt CA; Salvador-Silva M; Cavet ME; López FJ; Ward KW
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):437-46. PubMed ID: 19696178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5α-Tetrahydrocorticosterone: A topical anti-inflammatory glucocorticoid with an improved therapeutic index in a murine model of dermatitis.
    Livingstone DEW; Sooy K; Sykes C; Webster SP; Walker BR; Andrew R
    Br J Pharmacol; 2024 Apr; 181(8):1256-1267. PubMed ID: 37990638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEGRAs: a novel class of anti-inflammatory compounds.
    Schäcke H; Hennekes H; Schottelius A; Jaroch S; Lehmann M; Schmees N; Rehwinkel H; Asadullah K
    Ernst Schering Res Found Workshop; 2002; (40):357-71. PubMed ID: 12355726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy.
    Schoepe S; Schäcke H; Bernd A; Zöller N; Asadullah K
    Skin Pharmacol Physiol; 2010; 23(3):139-51. PubMed ID: 20051715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of GW870086: a potent anti-inflammatory steroid with a unique pharmacological profile.
    Uings IJ; Needham D; Matthews J; Haase M; Austin R; Angell D; Leavens K; Holt J; Biggadike K; Farrow SN
    Br J Pharmacol; 2013 Jul; 169(6):1389-403. PubMed ID: 23639214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index.
    Schäcke H; Berger M; Rehwinkel H; Asadullah K
    Mol Cell Endocrinol; 2007 Sep; 275(1-2):109-17. PubMed ID: 17630119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.